Matsumoto Fumi, Tohda Akira, Shimada Kenji
Department of Urology, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka 594-1101, Japan.
Int J Urol. 2004 Dec;11(12):1065-9. doi: 10.1111/j.1442-2042.2004.00967.x.
We retrospectively reviewed the results of ureteral reimplantation in infants with primary vesicoureteral reflux (VUR) to evaluate the effect on prevention of urinary tract infection (UTI) and renal growth.
From July 1991 to December 2001, a total of 205 infants (180 boys and 25 girls) with primary VUR underwent ureteral reimplantation at the Department of Urology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan. Indications for surgery were high-grade reflux (grade IV-V), breakthrough UTI and non-compliance of medical treatment. Age at surgery raged from 1 to 11 months (mean, 6.4 months). Ureteral reimplantation was performed according to Cohen's method. Only two of 336 refluxing ureters required ureteral tailoring. Follow-up ranged from 12 to 110 months (mean, 64 months). Surgical outcome, frequency of UTI and individual renal growth measured by (99m)Tc-dimercaptosuccinic acid (DMSA) scintigraphy was evaluated.
Postoperative ultrasound and voiding cystourethrography showed neither residual reflux nor ureterovesical obstruction. Contralateral low grade reflux occurred in six of 74 patients (8.1%) who had unilateral reflux preoperatively. After reimplantation, 10 patients documented 13 febrile UTI. Eleven of the 13 episodes occurred early in the postoperative period (<6 months). Frequency of febrile UTI reduced from 0.23538 before surgery to 0.00894 and 0.00081 per patient per month at 6 and 12 months after surgery, respectively. No development of renal scarring was seen in postoperative DMSA scan. Changes of differential renal function was <0.05 in all patients.
The present results show ureteral reimplantation in infants is safe and very effective for the prevention of UTI. After surgical treatment in infancy, individual renal growth of children with primary VUR is stable.
我们回顾性分析了原发性膀胱输尿管反流(VUR)患儿输尿管再植术的结果,以评估其对预防尿路感染(UTI)和肾脏生长的效果。
1991年7月至2001年12月,日本大阪母婴健康大阪医疗中心泌尿外科共有205例原发性VUR患儿(180例男孩和25例女孩)接受了输尿管再植术。手术指征为重度反流(IV-V级)、反复性UTI和药物治疗依从性差。手术年龄为1至11个月(平均6.4个月)。输尿管再植术按照科恩方法进行。336条反流输尿管中只有2条需要裁剪输尿管。随访时间为12至110个月(平均64个月)。评估手术结果、UTI发生频率以及通过(99m)锝-二巯基丁二酸(DMSA)闪烁扫描测量的个体肾脏生长情况。
术后超声和排尿性膀胱尿道造影显示既无残余反流也无输尿管膀胱梗阻。术前单侧反流的74例患者中有6例(8.1%)出现对侧轻度反流。再植术后,10例患者记录了13次发热性UTI。其中11次发作发生在术后早期(<6个月)。发热性UTI的发生率从术前的每位患者每月0.23538降至术后6个月和12个月时的每位患者每月0.00894和0.00081。术后DMSA扫描未发现肾脏瘢痕形成。所有患者的分肾功能变化<0.05。
目前的结果表明,婴儿输尿管再植术对于预防UTI是安全且非常有效的。婴儿期手术治疗后,原发性VUR患儿的个体肾脏生长稳定。